Where a device incorporates, as an integral part, a substance which, if used separately, may be considered to be a medicinal product as defined in Article 1 of Directive 65/65/EEC and which is liable to act upon the body with action ancillary to that of the device, the safety, quality and usefulness of the substance must be verified, taking account of the intended purpose of the device, by analogy with the appropriate methods specified in Directive 75/318/EEC.
Kadar pripomoček kot svoj sestavni del vsebuje snov, ki bi ob ločeni uporabi veljala za zdravilo, kot je opredeljeno v členu 1 Direktive 65/65/EGS, in ki naj bi delovala na telo z učinkom, ki dopolnjuje učinek pripomočka, je varnost, kakovost in uporabnost te snovi treba preveriti ob upoštevanju predvidenega namena pripomočka po analogiji z ustreznimi metodami, določenimi v Direktivi 75/318/EGS.